Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
By
Guardian US
Right out the toaster. Reliable, with some real depth.
Summary
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, achieving near-identical outcomes to those who undergo chemotherapy. This could potentially spare millions of breast cancer patients from chemotherapy.
Key quotes
· 1 pulledTrial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes
You might also wanna read
Study finds bird masturbation is natural behavior, not caused by captivity stress
A study on masturbation among birds, particularly parrots, finds that the behavior is natural and more common in the wild than in captivity.
theguardian.com·2h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·2h ago
Lab-grown sperm from stem cells could help infertile men, but may require gene editing
A US start-up called Paterna Biosciences claims it can take stem cells from men's testes and grow them into sperm cells in the lab, potentia
newscientist.com·3h ago
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
biotechniques.com·4h ago
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·4h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·5h ago